Insulin Delivery Devices-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data
Report Summary
Insulin Delivery Devices-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Insulin Delivery Devices industry, standing on the readers’ perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of Insulin Delivery Devices 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Insulin Delivery Devices worldwide and market share by regions, with company and product introduction, position in the Insulin Delivery Devices market
Market status and development trend of Insulin Delivery Devices by types and applications
Cost and profit status of Insulin Delivery Devices, and marketing status
Market growth drivers and challenges
The report segments the global Insulin Delivery Devices market as:
Global Insulin Delivery Devices Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Insulin Delivery Devices Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Insulin Pens (Reusable, Disposable)
Insulin Pumps (External/Tethered, Patch)
Pen Needles (Standard, Safety)
Insulin Syringes
Global Insulin Delivery Devices Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Patients/Homecare
Hospitals & Clinics
Global Insulin Delivery Devices Market: Manufacturers Segment Analysis (Company and Product introduction, Insulin Delivery Devices Sales Volume, Revenue, Price and Gross Margin):
Medtronic, Inc.
Becton
F. Hoffmann-La Roche
Abbott Laboratories
Novo Nordisk A/S
Eli Lilly and Company
Sanofi
Becton Dickinson
Insulet
B. Braun Melsungen AG
Animas Corporation
Ypsomed Holdings AG
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Insulin Delivery Devices-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Insulin Delivery Devices industry, standing on the readers’ perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of Insulin Delivery Devices 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Insulin Delivery Devices worldwide and market share by regions, with company and product introduction, position in the Insulin Delivery Devices market
Market status and development trend of Insulin Delivery Devices by types and applications
Cost and profit status of Insulin Delivery Devices, and marketing status
Market growth drivers and challenges
The report segments the global Insulin Delivery Devices market as:
Global Insulin Delivery Devices Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Insulin Delivery Devices Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Insulin Pens (Reusable, Disposable)
Insulin Pumps (External/Tethered, Patch)
Pen Needles (Standard, Safety)
Insulin Syringes
Global Insulin Delivery Devices Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Patients/Homecare
Hospitals & Clinics
Global Insulin Delivery Devices Market: Manufacturers Segment Analysis (Company and Product introduction, Insulin Delivery Devices Sales Volume, Revenue, Price and Gross Margin):
Medtronic, Inc.
Becton
F. Hoffmann-La Roche
Abbott Laboratories
Novo Nordisk A/S
Eli Lilly and Company
Sanofi
Becton Dickinson
Insulet
B. Braun Melsungen AG
Animas Corporation
Ypsomed Holdings AG
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF INSULIN DELIVERY DEVICES
1.1 Definition of Insulin Delivery Devices in This Report
1.2 Commercial Types of Insulin Delivery Devices
1.2.1 Insulin Pens (Reusable, Disposable)
1.2.2 Insulin Pumps (External/Tethered, Patch)
1.2.3 Pen Needles (Standard, Safety)
1.2.4 Insulin Syringes
1.3 Downstream Application of Insulin Delivery Devices
1.3.1 Patients/Homecare
1.3.2 Hospitals & Clinics
1.4 Development History of Insulin Delivery Devices
1.5 Market Status and Trend of Insulin Delivery Devices 2013-2023
1.5.1 Global Insulin Delivery Devices Market Status and Trend 2013-2023
1.5.2 Regional Insulin Delivery Devices Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Insulin Delivery Devices 2013-2017
2.2 Sales Market of Insulin Delivery Devices by Regions
2.2.1 Sales Volume of Insulin Delivery Devices by Regions
2.2.2 Sales Value of Insulin Delivery Devices by Regions
2.3 Production Market of Insulin Delivery Devices by Regions
2.4 Global Market Forecast of Insulin Delivery Devices 2018-2023
2.4.1 Global Market Forecast of Insulin Delivery Devices 2018-2023
2.4.2 Market Forecast of Insulin Delivery Devices by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Insulin Delivery Devices by Types
3.2 Sales Value of Insulin Delivery Devices by Types
3.3 Market Forecast of Insulin Delivery Devices by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Insulin Delivery Devices by Downstream Industry
4.2 Global Market Forecast of Insulin Delivery Devices by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Insulin Delivery Devices Market Status by Countries
5.1.1 North America Insulin Delivery Devices Sales by Countries (2013-2017)
5.1.2 North America Insulin Delivery Devices Revenue by Countries (2013-2017)
5.1.3 United States Insulin Delivery Devices Market Status (2013-2017)
5.1.4 Canada Insulin Delivery Devices Market Status (2013-2017)
5.1.5 Mexico Insulin Delivery Devices Market Status (2013-2017)
5.2 North America Insulin Delivery Devices Market Status by Manufacturers
5.3 North America Insulin Delivery Devices Market Status by Type (2013-2017)
5.3.1 North America Insulin Delivery Devices Sales by Type (2013-2017)
5.3.2 North America Insulin Delivery Devices Revenue by Type (2013-2017)
5.4 North America Insulin Delivery Devices Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Insulin Delivery Devices Market Status by Countries
6.1.1 Europe Insulin Delivery Devices Sales by Countries (2013-2017)
6.1.2 Europe Insulin Delivery Devices Revenue by Countries (2013-2017)
6.1.3 Germany Insulin Delivery Devices Market Status (2013-2017)
6.1.4 UK Insulin Delivery Devices Market Status (2013-2017)
6.1.5 France Insulin Delivery Devices Market Status (2013-2017)
6.1.6 Italy Insulin Delivery Devices Market Status (2013-2017)
6.1.7 Russia Insulin Delivery Devices Market Status (2013-2017)
6.1.8 Spain Insulin Delivery Devices Market Status (2013-2017)
6.1.9 Benelux Insulin Delivery Devices Market Status (2013-2017)
6.2 Europe Insulin Delivery Devices Market Status by Manufacturers
6.3 Europe Insulin Delivery Devices Market Status by Type (2013-2017)
6.3.1 Europe Insulin Delivery Devices Sales by Type (2013-2017)
6.3.2 Europe Insulin Delivery Devices Revenue by Type (2013-2017)
6.4 Europe Insulin Delivery Devices Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Insulin Delivery Devices Market Status by Countries
7.1.1 Asia Pacific Insulin Delivery Devices Sales by Countries (2013-2017)
7.1.2 Asia Pacific Insulin Delivery Devices Revenue by Countries (2013-2017)
7.1.3 China Insulin Delivery Devices Market Status (2013-2017)
7.1.4 Japan Insulin Delivery Devices Market Status (2013-2017)
7.1.5 India Insulin Delivery Devices Market Status (2013-2017)
7.1.6 Southeast Asia Insulin Delivery Devices Market Status (2013-2017)
7.1.7 Australia Insulin Delivery Devices Market Status (2013-2017)
7.2 Asia Pacific Insulin Delivery Devices Market Status by Manufacturers
7.3 Asia Pacific Insulin Delivery Devices Market Status by Type (2013-2017)
7.3.1 Asia Pacific Insulin Delivery Devices Sales by Type (2013-2017)
7.3.2 Asia Pacific Insulin Delivery Devices Revenue by Type (2013-2017)
7.4 Asia Pacific Insulin Delivery Devices Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Insulin Delivery Devices Market Status by Countries
8.1.1 Latin America Insulin Delivery Devices Sales by Countries (2013-2017)
8.1.2 Latin America Insulin Delivery Devices Revenue by Countries (2013-2017)
8.1.3 Brazil Insulin Delivery Devices Market Status (2013-2017)
8.1.4 Argentina Insulin Delivery Devices Market Status (2013-2017)
8.1.5 Colombia Insulin Delivery Devices Market Status (2013-2017)
8.2 Latin America Insulin Delivery Devices Market Status by Manufacturers
8.3 Latin America Insulin Delivery Devices Market Status by Type (2013-2017)
8.3.1 Latin America Insulin Delivery Devices Sales by Type (2013-2017)
8.3.2 Latin America Insulin Delivery Devices Revenue by Type (2013-2017)
8.4 Latin America Insulin Delivery Devices Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Insulin Delivery Devices Market Status by Countries
9.1.1 Middle East and Africa Insulin Delivery Devices Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Insulin Delivery Devices Revenue by Countries (2013-2017)
9.1.3 Middle East Insulin Delivery Devices Market Status (2013-2017)
9.1.4 Africa Insulin Delivery Devices Market Status (2013-2017)
9.2 Middle East and Africa Insulin Delivery Devices Market Status by Manufacturers
9.3 Middle East and Africa Insulin Delivery Devices Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Insulin Delivery Devices Sales by Type (2013-2017)
9.3.2 Middle East and Africa Insulin Delivery Devices Revenue by Type (2013-2017)
9.4 Middle East and Africa Insulin Delivery Devices Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF INSULIN DELIVERY DEVICES
10.1 Global Economy Situation and Trend Overview
10.2 Insulin Delivery Devices Downstream Industry Situation and Trend Overview
CHAPTER 11 INSULIN DELIVERY DEVICES MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Insulin Delivery Devices by Major Manufacturers
11.2 Production Value of Insulin Delivery Devices by Major Manufacturers
11.3 Basic Information of Insulin Delivery Devices by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Insulin Delivery Devices Major Manufacturer
11.3.2 Employees and Revenue Level of Insulin Delivery Devices Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 INSULIN DELIVERY DEVICES MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Medtronic, Inc.
12.1.1 Company profile
12.1.2 Representative Insulin Delivery Devices Product
12.1.3 Insulin Delivery Devices Sales, Revenue, Price and Gross Margin of Medtronic, Inc.
12.2 Becton
12.2.1 Company profile
12.2.2 Representative Insulin Delivery Devices Product
12.2.3 Insulin Delivery Devices Sales, Revenue, Price and Gross Margin of Becton
12.3 F. Hoffmann-La Roche
12.3.1 Company profile
12.3.2 Representative Insulin Delivery Devices Product
12.3.3 Insulin Delivery Devices Sales, Revenue, Price and Gross Margin of F. Hoffmann-La Roche
12.4 Abbott Laboratories
12.4.1 Company profile
12.4.2 Representative Insulin Delivery Devices Product
12.4.3 Insulin Delivery Devices Sales, Revenue, Price and Gross Margin of Abbott Laboratories
12.5 Novo Nordisk A/S
12.5.1 Company profile
12.5.2 Representative Insulin Delivery Devices Product
12.5.3 Insulin Delivery Devices Sales, Revenue, Price and Gross Margin of Novo Nordisk A/S
12.6 Eli Lilly and Company
12.6.1 Company profile
12.6.2 Representative Insulin Delivery Devices Product
12.6.3 Insulin Delivery Devices Sales, Revenue, Price and Gross Margin of Eli Lilly and Company
12.7 Sanofi
12.7.1 Company profile
12.7.2 Representative Insulin Delivery Devices Product
12.7.3 Insulin Delivery Devices Sales, Revenue, Price and Gross Margin of Sanofi
12.8 Becton Dickinson
12.8.1 Company profile
12.8.2 Representative Insulin Delivery Devices Product
12.8.3 Insulin Delivery Devices Sales, Revenue, Price and Gross Margin of Becton Dickinson
12.9 Insulet
12.9.1 Company profile
12.9.2 Representative Insulin Delivery Devices Product
12.9.3 Insulin Delivery Devices Sales, Revenue, Price and Gross Margin of Insulet
12.10 B. Braun Melsungen AG
12.10.1 Company profile
12.10.2 Representative Insulin Delivery Devices Product
12.10.3 Insulin Delivery Devices Sales, Revenue, Price and Gross Margin of B. Braun Melsungen AG
12.11 Animas Corporation
12.11.1 Company profile
12.11.2 Representative Insulin Delivery Devices Product
12.11.3 Insulin Delivery Devices Sales, Revenue, Price and Gross Margin of Animas Corporation
12.12 Ypsomed Holdings AG
12.12.1 Company profile
12.12.2 Representative Insulin Delivery Devices Product
12.12.3 Insulin Delivery Devices Sales, Revenue, Price and Gross Margin of Ypsomed Holdings AG
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF INSULIN DELIVERY DEVICES
13.1 Industry Chain of Insulin Delivery Devices
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF INSULIN DELIVERY DEVICES
14.1 Cost Structure Analysis of Insulin Delivery Devices
14.2 Raw Materials Cost Analysis of Insulin Delivery Devices
14.3 Labor Cost Analysis of Insulin Delivery Devices
14.4 Manufacturing Expenses Analysis of Insulin Delivery Devices
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
1.1 Definition of Insulin Delivery Devices in This Report
1.2 Commercial Types of Insulin Delivery Devices
1.2.1 Insulin Pens (Reusable, Disposable)
1.2.2 Insulin Pumps (External/Tethered, Patch)
1.2.3 Pen Needles (Standard, Safety)
1.2.4 Insulin Syringes
1.3 Downstream Application of Insulin Delivery Devices
1.3.1 Patients/Homecare
1.3.2 Hospitals & Clinics
1.4 Development History of Insulin Delivery Devices
1.5 Market Status and Trend of Insulin Delivery Devices 2013-2023
1.5.1 Global Insulin Delivery Devices Market Status and Trend 2013-2023
1.5.2 Regional Insulin Delivery Devices Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Insulin Delivery Devices 2013-2017
2.2 Sales Market of Insulin Delivery Devices by Regions
2.2.1 Sales Volume of Insulin Delivery Devices by Regions
2.2.2 Sales Value of Insulin Delivery Devices by Regions
2.3 Production Market of Insulin Delivery Devices by Regions
2.4 Global Market Forecast of Insulin Delivery Devices 2018-2023
2.4.1 Global Market Forecast of Insulin Delivery Devices 2018-2023
2.4.2 Market Forecast of Insulin Delivery Devices by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Insulin Delivery Devices by Types
3.2 Sales Value of Insulin Delivery Devices by Types
3.3 Market Forecast of Insulin Delivery Devices by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Insulin Delivery Devices by Downstream Industry
4.2 Global Market Forecast of Insulin Delivery Devices by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Insulin Delivery Devices Market Status by Countries
5.1.1 North America Insulin Delivery Devices Sales by Countries (2013-2017)
5.1.2 North America Insulin Delivery Devices Revenue by Countries (2013-2017)
5.1.3 United States Insulin Delivery Devices Market Status (2013-2017)
5.1.4 Canada Insulin Delivery Devices Market Status (2013-2017)
5.1.5 Mexico Insulin Delivery Devices Market Status (2013-2017)
5.2 North America Insulin Delivery Devices Market Status by Manufacturers
5.3 North America Insulin Delivery Devices Market Status by Type (2013-2017)
5.3.1 North America Insulin Delivery Devices Sales by Type (2013-2017)
5.3.2 North America Insulin Delivery Devices Revenue by Type (2013-2017)
5.4 North America Insulin Delivery Devices Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Insulin Delivery Devices Market Status by Countries
6.1.1 Europe Insulin Delivery Devices Sales by Countries (2013-2017)
6.1.2 Europe Insulin Delivery Devices Revenue by Countries (2013-2017)
6.1.3 Germany Insulin Delivery Devices Market Status (2013-2017)
6.1.4 UK Insulin Delivery Devices Market Status (2013-2017)
6.1.5 France Insulin Delivery Devices Market Status (2013-2017)
6.1.6 Italy Insulin Delivery Devices Market Status (2013-2017)
6.1.7 Russia Insulin Delivery Devices Market Status (2013-2017)
6.1.8 Spain Insulin Delivery Devices Market Status (2013-2017)
6.1.9 Benelux Insulin Delivery Devices Market Status (2013-2017)
6.2 Europe Insulin Delivery Devices Market Status by Manufacturers
6.3 Europe Insulin Delivery Devices Market Status by Type (2013-2017)
6.3.1 Europe Insulin Delivery Devices Sales by Type (2013-2017)
6.3.2 Europe Insulin Delivery Devices Revenue by Type (2013-2017)
6.4 Europe Insulin Delivery Devices Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Insulin Delivery Devices Market Status by Countries
7.1.1 Asia Pacific Insulin Delivery Devices Sales by Countries (2013-2017)
7.1.2 Asia Pacific Insulin Delivery Devices Revenue by Countries (2013-2017)
7.1.3 China Insulin Delivery Devices Market Status (2013-2017)
7.1.4 Japan Insulin Delivery Devices Market Status (2013-2017)
7.1.5 India Insulin Delivery Devices Market Status (2013-2017)
7.1.6 Southeast Asia Insulin Delivery Devices Market Status (2013-2017)
7.1.7 Australia Insulin Delivery Devices Market Status (2013-2017)
7.2 Asia Pacific Insulin Delivery Devices Market Status by Manufacturers
7.3 Asia Pacific Insulin Delivery Devices Market Status by Type (2013-2017)
7.3.1 Asia Pacific Insulin Delivery Devices Sales by Type (2013-2017)
7.3.2 Asia Pacific Insulin Delivery Devices Revenue by Type (2013-2017)
7.4 Asia Pacific Insulin Delivery Devices Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Insulin Delivery Devices Market Status by Countries
8.1.1 Latin America Insulin Delivery Devices Sales by Countries (2013-2017)
8.1.2 Latin America Insulin Delivery Devices Revenue by Countries (2013-2017)
8.1.3 Brazil Insulin Delivery Devices Market Status (2013-2017)
8.1.4 Argentina Insulin Delivery Devices Market Status (2013-2017)
8.1.5 Colombia Insulin Delivery Devices Market Status (2013-2017)
8.2 Latin America Insulin Delivery Devices Market Status by Manufacturers
8.3 Latin America Insulin Delivery Devices Market Status by Type (2013-2017)
8.3.1 Latin America Insulin Delivery Devices Sales by Type (2013-2017)
8.3.2 Latin America Insulin Delivery Devices Revenue by Type (2013-2017)
8.4 Latin America Insulin Delivery Devices Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Insulin Delivery Devices Market Status by Countries
9.1.1 Middle East and Africa Insulin Delivery Devices Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Insulin Delivery Devices Revenue by Countries (2013-2017)
9.1.3 Middle East Insulin Delivery Devices Market Status (2013-2017)
9.1.4 Africa Insulin Delivery Devices Market Status (2013-2017)
9.2 Middle East and Africa Insulin Delivery Devices Market Status by Manufacturers
9.3 Middle East and Africa Insulin Delivery Devices Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Insulin Delivery Devices Sales by Type (2013-2017)
9.3.2 Middle East and Africa Insulin Delivery Devices Revenue by Type (2013-2017)
9.4 Middle East and Africa Insulin Delivery Devices Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF INSULIN DELIVERY DEVICES
10.1 Global Economy Situation and Trend Overview
10.2 Insulin Delivery Devices Downstream Industry Situation and Trend Overview
CHAPTER 11 INSULIN DELIVERY DEVICES MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Insulin Delivery Devices by Major Manufacturers
11.2 Production Value of Insulin Delivery Devices by Major Manufacturers
11.3 Basic Information of Insulin Delivery Devices by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Insulin Delivery Devices Major Manufacturer
11.3.2 Employees and Revenue Level of Insulin Delivery Devices Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 INSULIN DELIVERY DEVICES MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Medtronic, Inc.
12.1.1 Company profile
12.1.2 Representative Insulin Delivery Devices Product
12.1.3 Insulin Delivery Devices Sales, Revenue, Price and Gross Margin of Medtronic, Inc.
12.2 Becton
12.2.1 Company profile
12.2.2 Representative Insulin Delivery Devices Product
12.2.3 Insulin Delivery Devices Sales, Revenue, Price and Gross Margin of Becton
12.3 F. Hoffmann-La Roche
12.3.1 Company profile
12.3.2 Representative Insulin Delivery Devices Product
12.3.3 Insulin Delivery Devices Sales, Revenue, Price and Gross Margin of F. Hoffmann-La Roche
12.4 Abbott Laboratories
12.4.1 Company profile
12.4.2 Representative Insulin Delivery Devices Product
12.4.3 Insulin Delivery Devices Sales, Revenue, Price and Gross Margin of Abbott Laboratories
12.5 Novo Nordisk A/S
12.5.1 Company profile
12.5.2 Representative Insulin Delivery Devices Product
12.5.3 Insulin Delivery Devices Sales, Revenue, Price and Gross Margin of Novo Nordisk A/S
12.6 Eli Lilly and Company
12.6.1 Company profile
12.6.2 Representative Insulin Delivery Devices Product
12.6.3 Insulin Delivery Devices Sales, Revenue, Price and Gross Margin of Eli Lilly and Company
12.7 Sanofi
12.7.1 Company profile
12.7.2 Representative Insulin Delivery Devices Product
12.7.3 Insulin Delivery Devices Sales, Revenue, Price and Gross Margin of Sanofi
12.8 Becton Dickinson
12.8.1 Company profile
12.8.2 Representative Insulin Delivery Devices Product
12.8.3 Insulin Delivery Devices Sales, Revenue, Price and Gross Margin of Becton Dickinson
12.9 Insulet
12.9.1 Company profile
12.9.2 Representative Insulin Delivery Devices Product
12.9.3 Insulin Delivery Devices Sales, Revenue, Price and Gross Margin of Insulet
12.10 B. Braun Melsungen AG
12.10.1 Company profile
12.10.2 Representative Insulin Delivery Devices Product
12.10.3 Insulin Delivery Devices Sales, Revenue, Price and Gross Margin of B. Braun Melsungen AG
12.11 Animas Corporation
12.11.1 Company profile
12.11.2 Representative Insulin Delivery Devices Product
12.11.3 Insulin Delivery Devices Sales, Revenue, Price and Gross Margin of Animas Corporation
12.12 Ypsomed Holdings AG
12.12.1 Company profile
12.12.2 Representative Insulin Delivery Devices Product
12.12.3 Insulin Delivery Devices Sales, Revenue, Price and Gross Margin of Ypsomed Holdings AG
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF INSULIN DELIVERY DEVICES
13.1 Industry Chain of Insulin Delivery Devices
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF INSULIN DELIVERY DEVICES
14.1 Cost Structure Analysis of Insulin Delivery Devices
14.2 Raw Materials Cost Analysis of Insulin Delivery Devices
14.3 Labor Cost Analysis of Insulin Delivery Devices
14.4 Manufacturing Expenses Analysis of Insulin Delivery Devices
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
